ZA829408B - Use of peptides as medicament - Google Patents
Use of peptides as medicamentInfo
- Publication number
- ZA829408B ZA829408B ZA829408A ZA829408A ZA829408B ZA 829408 B ZA829408 B ZA 829408B ZA 829408 A ZA829408 A ZA 829408A ZA 829408 A ZA829408 A ZA 829408A ZA 829408 B ZA829408 B ZA 829408B
- Authority
- ZA
- South Africa
- Prior art keywords
- peptides
- medicament
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK576381 | 1981-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA829408B true ZA829408B (en) | 1983-10-26 |
Family
ID=8145055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA829408A ZA829408B (en) | 1981-12-23 | 1982-12-22 | Use of peptides as medicament |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0082731A1 (el) |
JP (1) | JPS58116421A (el) |
AU (1) | AU9188382A (el) |
BE (1) | BE895432A (el) |
DE (1) | DE3247786A1 (el) |
GB (1) | GB2112641A (el) |
GR (1) | GR78411B (el) |
IT (1) | IT1155438B (el) |
LU (1) | LU84546A1 (el) |
NZ (1) | NZ202757A (el) |
ZA (1) | ZA829408B (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
EP0587255A1 (en) * | 1986-05-05 | 1994-03-16 | The General Hospital Corporation | Insulinotropic hormone |
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
GB9409496D0 (en) | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
US5574008A (en) * | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide |
US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
ATE520714T1 (de) | 2007-06-15 | 2011-09-15 | Zealand Pharma As | Glucagonanaloga |
EP2025684A1 (en) * | 2007-08-15 | 2009-02-18 | Zealand Pharma A/S | Glucagon analogues |
MY160219A (en) | 2008-12-15 | 2017-02-28 | Zealand Pharma As | Glucagon analogues |
MX2011006315A (es) | 2008-12-15 | 2011-09-22 | Zealand Pharma As | Analogos de glucagon. |
EA020520B1 (ru) | 2008-12-15 | 2014-11-28 | Зилэнд Фарма А/С | Аналоги глюкагона |
CN102282166B (zh) | 2008-12-15 | 2015-04-01 | 西兰制药公司 | 胰高血糖素类似物 |
MX2012000564A (es) | 2009-07-13 | 2012-04-11 | Zealand Pharma As | Analogos de glucagon acilados. |
AR081975A1 (es) | 2010-06-23 | 2012-10-31 | Zealand Pharma As | Analogos de glucagon |
AP2013006671A0 (en) | 2010-06-24 | 2013-01-31 | Zealand Pharma As | Glucagon analogues |
WO2013164483A1 (en) | 2012-05-03 | 2013-11-07 | Zealand Pharma A/S | Gip-glp-1 dual agonist compounds and methods |
DK2875043T3 (en) | 2012-07-23 | 2017-03-27 | Zealand Pharma As | glucagon |
TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
KR102394515B1 (ko) | 2013-10-17 | 2022-05-09 | 질랜드 파마 에이/에스 | 아실화된 글루카곤 유사체 |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
US10131702B2 (en) | 2013-11-06 | 2018-11-20 | Zealand Pharma A/S | Glucagon-GLP-1-GIP triple agonist compounds |
US10093713B2 (en) | 2013-11-06 | 2018-10-09 | Zealand Pharma A/S | GIP-GLP-1 dual agonist compounds and methods |
CA2965732A1 (en) | 2014-10-29 | 2016-05-06 | Zealand Pharma A/S | Gip agonist compounds and methods |
PL3283507T3 (pl) | 2015-04-16 | 2020-05-18 | Zealand Pharma A/S | Acylowany analog glukagonu |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK283180A (da) * | 1980-07-01 | 1982-01-02 | Novo Industri As | Polypeptider og derivater deraf |
-
1982
- 1982-12-09 NZ NZ202757A patent/NZ202757A/en unknown
- 1982-12-21 BE BE6/47758A patent/BE895432A/fr not_active IP Right Cessation
- 1982-12-22 ZA ZA829408A patent/ZA829408B/xx unknown
- 1982-12-22 LU LU84546A patent/LU84546A1/de unknown
- 1982-12-22 GR GR70154A patent/GR78411B/el unknown
- 1982-12-22 GB GB08236403A patent/GB2112641A/en not_active Withdrawn
- 1982-12-22 EP EP82306879A patent/EP0082731A1/en not_active Withdrawn
- 1982-12-22 IT IT24915/82A patent/IT1155438B/it active
- 1982-12-22 JP JP57225755A patent/JPS58116421A/ja active Pending
- 1982-12-23 AU AU91883/82A patent/AU9188382A/en not_active Abandoned
- 1982-12-23 DE DE19823247786 patent/DE3247786A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GR78411B (el) | 1984-09-27 |
BE895432A (fr) | 1983-06-21 |
IT8224915A0 (it) | 1982-12-22 |
JPS58116421A (ja) | 1983-07-11 |
DE3247786A1 (de) | 1983-07-21 |
IT1155438B (it) | 1987-01-28 |
LU84546A1 (de) | 1983-09-08 |
GB2112641A (en) | 1983-07-27 |
IT8224915A1 (it) | 1984-06-22 |
NZ202757A (en) | 1985-11-08 |
EP0082731A1 (en) | 1983-06-29 |
AU9188382A (en) | 1983-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA829408B (en) | Use of peptides as medicament | |
DE3273153D1 (en) | Pharmaceutical mixture | |
ZA848375B (en) | Medicament formulation | |
DE3273948D1 (en) | Pharmaceutical preparations | |
EP0070525A3 (en) | Pharmaceutical preparations for external use | |
GB2116042B (en) | Injector for medical uses | |
DE3264782D1 (en) | Medicinal formulation | |
PH19309A (en) | Treatment of aluminous materials | |
JPS57149230A (en) | Medicinal composition | |
PT75889B (en) | Therapeutic agent | |
DE3261760D1 (en) | Pharmaceutical compositions for the treatment of skin | |
JPS57198100A (en) | Treatment of mollases | |
GB2119365B (en) | Preparation of azinomethyl-rifamycins | |
JPS57206615A (en) | Medicinal composition containing guanfasin | |
IL67432A (en) | Preparation of hetaryloxyacetamides | |
JPS57166993A (en) | Preparation of chunicamycin | |
PH18457A (en) | Pharmaceutical preparations | |
IL66419A0 (en) | Preparation of 4-amino-butyramide | |
ZA822120B (en) | Pharmaceutical preparation | |
GB8322272D0 (en) | Peptides as medicament | |
IL65060A (en) | Preparation of 4-hydroxy-6-methyl-2-pyrone | |
GB2110676B (en) | Preparation of 3-alkoxycycloalk-2-en-1-ones | |
DE3170230D1 (en) | Therapeutic agent | |
JPS57139070A (en) | Medicinal composition | |
JPS57169418A (en) | Guanopyrimidine-containing novel medicinal composition |